Effects of traditional chinese medicine on intestinal mucosal permeability in early phase of severe acute pancreatitis

Chinese Medical Journal

Volumn 123, Issue 12, 2010, Pages 1537-1542

  Chen, Hong ^a   Li, Fei ^a   Jia, Jian Guo ^a   Diao, Yong Peng ^a   Li, Zong Xin ^a   Sun, Jia Bang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute necrotizing; Bacterial translocation; Chinese traditional; Dachengqi decoction; Medicine; Pancreatitis

Indexed keywords

C REACTIVE PROTEIN; CHINESE DRUG; DACHENGQI; ENDOTOXIN; INTERLEUKIN 6; LACTULOSE; LIPOPOLYSACCHARIDE; MANNITOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HUMAN; INTESTINE MUCOSA PERMEABILITY; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PANCREAS DISEASE; PANCREAS INFECTION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; UNSPECIFIED SIDE EFFECT; URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PANCREATITIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79851499038     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.12.011     Document Type: Article

References (46)

1. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg 1997; 21: 130-135.
2. Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999; 3: 252-262.
3. Ammori BJ. Gut barrier dysfunction in patients with acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 411-412.
4. Cheng YX, Wang M, Cheng X. Effect of dachaihu decoction in treating acute mild pancreatitis of Gan-qi stagnant type. Chin J Integr Tradit West Med (Chin) 2008; 28: 793-796.
5. Xue P, Deng LH, Zhang ZD, Yang XN, Xia Q, Xiang DK, et al. Chaiqin Chengqi Decoction decreases pancreatic acinar cell calcium overload in rats with acute pancreatitis. J Chin Integr Med (Chin) 2008; 6: 1054-1058.
6. Zhang MJ, Zhang GL, Yuan WB, Ni J, Huang LF. Treatment of abdominal compartment syndrome in severe acute pancreatitis patients with traditional Chinese medicine. World J Gastroenterol 2008; 14: 3574-3578.
7. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.
8. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101: 2379-2400.
9. Sörensen SH, Proud FJ, Adam A, Rutgers HC, Batt RM. A novel HPLC method for the simultaneous quantification of monosaccharides and disaccharides used in tests of intestinal function and permeability. Clin Chim Acta 1993; 221: 115-125.
10. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliabledescriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638-1652.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
12. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69-81.
13. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-336.
14. Mao EQ, Tang YQ, Fei J, Qin S, Wu J, Li L, et al. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J 2009; 122: 169-173.
15. Peng JS, Liu ZH, Li CJ, Wu XB, Diao DC, Du YP, et al. Development of a real-time PCR method for the detection of bacterial colonization in rat models of severe acute pancreatitis. Chin Med J 2010; 123: 326-331.
16. Yang DJ, He YL, Cai SR, Peng JJ, Zhang CH, Zhan WH. Early operation for fulminant acute pancreatitis: a possible way to decrease mortality. Chin Med J 2009; 122: 1492-1494.
17. Nagpal K, Minocha VR, Agrawal V, Kapur S. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg 2006; 192: 24-28.
18. Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil 2005; 26: 383-391.
19. Penalva JC, Martínez J, Laveda R, Esteban A, Muñoz C, Sáez J, et al. A study of intestinal permeability in relation to the inflammatory response and plasma endocab IgM levels in patients with acute pancreatitis. J Clin Gastroenterol 2004; 38:512-517.
20. Liu H, Li W, Wang X, Li J, Yu W. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 2008; 36: 192-196.
21. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in the gnotobiotic mouse model. InfectImmun 1979; 23: 403-411.
22. Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis-a prospective clinicalstudy. Gastroenterology 1986; 91: 433-438.
23. Gloor B, Muller CA, Worni M, Stahel PF, Redaelli C, Uhl W, et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001; 136: 592-596.
24. Bittner R, Block S, Buchler M, Beger HG. Pancreatic abscess and infected pancreatic necrosis: different local septiccomplications in acute pancreatitis. Dig Dis Sci 1987; 32: 1082-1087.
25. Fedorak IJ, Ko TC, Djuricin G, McMahon M, Thompson K, Prinz RA. Secondary pancreatic infections: are they distinct clinical entities? Surgery 1992; 112: 824-831.
26. Bradley EL 3rd. A fifteen-year experience with open drainage for infected pancreatic necrosis. Surg Gynecol Obstet 1993; 177: 215-222.
27. Farkas G, Márton J, Mándi Y, Szederkényi E. Surgical strategy and management of infected pancreatic necrosis. Br J Surg 1996; 83: 930-933.
28. Rau B, Uhl W, Buchler MW, Beger HG. Surgical treatment of infected necrosis. World J Surg 1997; 21: 155-161.
29. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995; 117: 68-655.
30. Fink GW, Norman JG. Specific changes in the pancreatic expression of the interleukin-1 family of genes during experimental acute pancreatitis. Cytokine 1997; 9: 1023-1027.
31. Fu K, Sarras MP Jr, De Lisle RC, Andrews GK. Expression of oxidative stress responsive genes and cytokine genes during caerulein-induced acute pancreatitis. Am J Physiol 1997; 273 (3 Pt 1): G696-G705.
32. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83: 349-353.
33. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in humanbeings? Surgery 2002; 131: 241-244.
34. Guice KS, Oldham KT, Caty MG, Johnson KJ, Ward PA. Neutrophil-dependent, oxygen-radical mediated lung injuryassociated with acute pancreatitis. Ann Surg 1989; 210: 740-747.
35. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor-α. Cytokine 1991; 3: 12-16.
36. de Beaux AC, Ross JA, Maingay JP, Fearon KC, Carter DC. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996; 83: 1071-1075.
37. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996; 83: 919-923.
38. Zhang XP, Liu DR, Shi Y. Study progress in therapeutic effects of traditional Chinese medicine monomer in severe acute pancreatitis. J Zhejiang Univ Sci B 2007; 8: 147-152.
39. Zhang XP, Shi Y, Zhang L. Progress in the study of therapeutic effects of traditional Chinese medicine and extracts in treating severe acute pancreatitis. JOP 2007; 8: 704-714.
40. Qiong W, Yiping W, Jinlin Y, Tao G, Zhen G, Pengcheng Z. Chinese medicinal herbs for acute pancreatitis. Cochrane Database Syst Rev 2005; (1): CD003631.
41. Zhao YQ, Liu XH, Ito T, Qian JM. Protective effects of rhubarb on experimental severe acute pancreatitis. World J Gastroenterol 2004; 10: 1005-1009.
42. Pardo A, Bartoli R, Lorenzo-Zuniga V, Planas R, Vinado B, Riba J, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858-863.
43. Zhang SC, Wang W, Ren WY, He BM, Zhou K, Zhu WN. Effect of cisapride on intestinal bacterial and endotoxintranslocation in cirrhosis. World J Gastroenterol 2003; 9: 534-538.
44. General Surgery Committee, Chinese Association of the Integration of Traditional and Western Medicine. Practical guidelines for management of severe acute pancreatitis with integrated Chinese traditional and Western medicine (Draft). Chin Crit Care Med (Chin) 2007; 19: 448-451.
45. Gu XD, Zhang Q. Clinical progress in the treatment of severe acute pancreatitis with integrative Chinese and Western medicine. Chin J Integr Med 2007; 13: 235-240.
46. Zhang M, Zhu DZ, Li ZS, Zhan XB. Red peony root decoction in treatment of severe acute pancreatitis: a randomized controlled trial. J Chin Integr Med (Chin) 2008; 6: 569-575.